150 related articles for article (PubMed ID: 10924736)
1. The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
Pihlajamäki J; Miettinen R; Valve R; Karjalainen L; Mykkänen L; Kuusisto J; Deeb S; Auwerx J; Laakso M
Atherosclerosis; 2000 Aug; 151(2):567-74. PubMed ID: 10924736
[TBL] [Abstract][Full Text] [Related]
2. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.
Pihlajamäki J; Rissanen J; Heikkinen S; Karjalainen L; Laakso M
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1039-44. PubMed ID: 9194752
[TBL] [Abstract][Full Text] [Related]
3. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.
Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Taskinen MR; Deeb SS; Laakso M
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1789-95. PubMed ID: 10894818
[TBL] [Abstract][Full Text] [Related]
4. A major gene effect on fasting insulin and insulin sensitivity in familial combined hyperlipidemia.
Pihlajamäki J; Austin M; Edwards K; Laakso M
Diabetes; 2001 Oct; 50(10):2396-401. PubMed ID: 11574425
[TBL] [Abstract][Full Text] [Related]
5. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
[TBL] [Abstract][Full Text] [Related]
6. C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients.
Ylitalo K; Nuotio I; Viikari J; Auwerx J; Vidal H; Taskinen MR
Metabolism; 2002 May; 51(5):664-70. PubMed ID: 11979403
[TBL] [Abstract][Full Text] [Related]
7. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
[TBL] [Abstract][Full Text] [Related]
8. The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance.
Pihlajamäki J; Valve R; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
Eur J Clin Invest; 2001 Apr; 31(4):302-8. PubMed ID: 11298776
[TBL] [Abstract][Full Text] [Related]
9. Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?
Karjalainen L; Pihlajamäki J; Karhapää P; Laakso M
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1548-53. PubMed ID: 9763525
[TBL] [Abstract][Full Text] [Related]
10. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
[TBL] [Abstract][Full Text] [Related]
11. Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents. The STRIP project.
Lapinleimu J; Nuotio IO; Lapinleimu H; Simell OG; Rask-Nissila L; Viikari JS
Atherosclerosis; 2002 Feb; 160(2):417-23. PubMed ID: 11849666
[TBL] [Abstract][Full Text] [Related]
12. Increased arterial stiffness in familial combined hyperlipidemia.
Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
[TBL] [Abstract][Full Text] [Related]
13. Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.
Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):164-70. PubMed ID: 10634813
[TBL] [Abstract][Full Text] [Related]
14. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease.
Lee JC; Weissglas-Volkov D; Kyttälä M; Sinsheimer JS; Jokiaho A; de Bruin TW; Lusis AJ; Brennan ML; van Greevenbroek MM; van der Kallen CJ; Hazen SL; Pajukanta P
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2222-7. PubMed ID: 17673701
[TBL] [Abstract][Full Text] [Related]
15. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.
Douglas JA; Erdos MR; Watanabe RM; Braun A; Johnston CL; Oeth P; Mohlke KL; Valle TT; Ehnholm C; Buchanan TA; Bergman RN; Collins FS; Boehnke M; Tuomilehto J
Diabetes; 2001 Apr; 50(4):886-90. PubMed ID: 11289057
[TBL] [Abstract][Full Text] [Related]
16. [Genetic factors in familial combined hyperlipidemia and insulin resistance syndrome associated with dyslipidemia].
Moulin P
Ann Endocrinol (Paris); 1997; 58(4):287-91. PubMed ID: 9436476
[TBL] [Abstract][Full Text] [Related]
17. Reduced structural and functional skin capillaries in familial combined hyperlipidemia affected men, associated with increased remnant-like lipoprotein cholesterol levels.
Keulen ET; Schaper NC; Houben AJ; van Lin JM; Lutgens I; Rijkers K; Dallinga-Thie GM; de Bruin TW
Atherosclerosis; 2002 Aug; 163(2):355-62. PubMed ID: 12052483
[TBL] [Abstract][Full Text] [Related]
18. Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Geurts JM; Flavell DM; de Bruin TW
Mol Genet Metab; 2002 Dec; 77(4):274-81. PubMed ID: 12468272
[TBL] [Abstract][Full Text] [Related]
19. Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.
Campagna F; Montali A; Baroni MG; Maria AT; Ricci G; Antonini R; Verna R; Arca M
Metabolism; 2002 Oct; 51(10):1298-305. PubMed ID: 12370850
[TBL] [Abstract][Full Text] [Related]
20. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY
J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
